Medical Oncology
The Division of Medical Oncology focuses on systemic therapy for patients with cancer. We are actively involved in improving the outcome of patients through research and quality improvement programs. Members of the Division are responsible for education and training of undergraduate and postgraduate students and the continuous professional development of practitioners.
Our research programs range from basic, bench-top research to clinical bedside research. In addition, there are translational research programs and active drug development research protocols. We are leaders in the establishment of tissue banking and research on these samples and collaborate on local, national and international studies.
Members of the Division of Medical Oncology participate in many aspects of cancer research, spanning preclinical models of cancer and drug resistance, translational efforts bringing biomarkers and new drugs to patients, clinical trials, and outcomes research. Areas of research strength include: